Home > About
HekaBio is a pre-commercial stage company
comprised of a diverse group of healthcare experts
We in-license and invest in leading global innovations, with an initial focus on oncology and radiation therapy, and successfully
We intend to realize significant benefit for patients and healthcare systems in Japan and Asia
3-3-16 Nihonbashihongokucho, Chuo-ku, Tokyo , Japan
November 14, 2016
Robert E. Claar
Clinical and regulatory development, importation and sales of medical devices, in-vitro diagnostics, pharmaceuticals and regenerative medicine products
Vorpal Technologies K.K.
Meaning of “Heka”
In Egyptian mythology, Heka is the personification of healing and magic. Heka literally means “engaging the spirit or vital force”.
We maintain internal and external relationships built on common goals,
mutual respect, open communication, trust and teamwork
We approach problems with a positive attitude, acting on needs and
opportunities to deliver inspired solutions
We are self-starters who mobilize our knowledge, expertise, diligence,
and networks to ensure successful execution
Robert E. Claar
Chief Executive Officer,
Rob creates new businesses that address the unmet needs of patients, doctors, innovators and authorities. He is passionate about developing innovative solutions for access to Japan’s healthcare market. Over three decades, Rob has founded a number of businesses including Junicon, a global healthcare marketing research consultancy, and Vorpal Technologies, a MedTech regulatory consultancy. He maintains a worldwide trust network with leading innovators in MedTech and pharma through optimism, tenacious follow-through and a spirit of collaboration.
Benjamin D. Pratt
Chief Operating Officer,
Ben has two decades of experience in strategy development, marketing, and operations, and has commercialized and marketed best-in-class medical products globally and in Japan. As GM at Vorpal Technologies, he consulted overseas healthcare innovators and launched Vorpal Women’s Health, a Vorpal commercial entity sold in 2017. His forte and personal mission is creating new businesses for the betterment of patient care. Ben holds an MBA from the University of Southern California.
Anne Bille, MD, PhD, MPH
Chief Medical Officer
Anne is the former head of Medical Affairs, Clinical Development and Operations at Baxalta and Baxter Japan and was Medical Director for programs at Wyeth Japan and Eli Lilly Japan. Anne is a psychiatry medical doctor and has a track record of leading successful regulatory and clinical programs in oncology, CNS, hemophilia and anesthesia. Anne has been a resident of Japan for 19 years.
Chief Financial Officer
Hitoshi has 30 years of leadership experience in the life science industry including both large and venture biotech and pharmaceutical companies in executive management, finance, business development, and commercial roles.
Hitoshi’s background as a research scientist and financial professional make him a hands-on manager in biotech startups. He is experienced in private equity fundraising and IPO preparation and holds MBA & USCPA qualifications.
Director, Business Development
Russ has over two decades of business experience in Japan, and 16 years’ experience leading marketing, sales and clinical research functions for cardiovascular and neuromodulation businesses at Medtronic with Japan and Asia Pacific responsibilities.
Russ maintains strong relationships with thought leaders in many areas of cardiovascular medicine. He holds an MBA from the University of Michigan.